Yahoo Finance Documents the FutureCeuticals Caffinity Clinical Study Results
According to a June 10 Yahoo Finance announcement distributed through Morningstar and PR Newswire, FutureCeuticals has published peer-reviewed clinical research on Caffinity, a proprietary ingredient derived from the Arabica coffee cherry. According to the coverage, the study was conducted at the University of Exeter in the United Kingdom. A 286 milligram dose of Caffinity, which provides 200 milligrams of caffeine alongside coffee fruit polyphenols, produced a nearly 5 percent average improvement in time trial performance among trained cyclists when compared with placebo.
Study Documents Fat Mobilization Glucose Stability and Faster Lactate Clearance
According to the same June 10 PR Newswire coverage of the Caffinity research, the published study also documented several additional metabolic benefits beyond performance alone. According to the underlying research, Caffinity increased fat mobilization and ketone availability during recovery, helped stabilize blood glucose during exercise, and supported faster lactate clearance after activity. The researchers framed these findings as evidence that natural complexes of caffeine and coffee fruit polyphenols can deliver performance benefits while avoiding some of the spike-and-crash patterns associated with isolated high-dose caffeine.
LinkedIn Report Documents Europe Caffeine Powder Market Size and Growth
According to a June 10 LinkedIn distribution of new market research, the Europe caffeine powder market continues to expand. According to the coverage, the segment is being driven by sports nutrition demand, functional beverage formulation needs, and the broader 2026 consumer migration toward naturally derived caffeine sources. The market expansion reflects the maturation of the broader caffeine ingredient category as manufacturers seek transparent and verifiable sources for their formulations.
Logos Press Reports Lavazza Launches Coffee Capsule Alternative in the US Market
According to a June 9 Logos Press report referenced through June 10 industry coverage, Lavazza has launched an alternative to traditional coffee capsules in the US market. According to the coverage, the launch reflects the broader 2026 industry trend toward sustainable packaging, dose-precise delivery formats, and consumer demand for ingredient transparency across the at-home coffee category. The product extension signals continued investment by major incumbent operators in the broader coffee category innovation cycle.
Jiggle’s caffeine gummies sit inside the same naturally derived, dose-precise caffeine category that the June 10 Yahoo Finance, Morningstar, and Logos Press coverage identifies as the fastest-growing segment of the modern caffeine market. Each gummy delivers a known and fixed dose of natural caffeine sourced from green tea extract and guarana. The format pairs caffeine with the polyphenol-rich plant matrix that the latest Caffinity research treats as the foundation for smooth energy and metabolic recovery. With no artificial ingredients, GMP-certified manufacturing, and a resealable 12-pack at $18.99, the product captures the modern natural caffeine consumer that the broader market data identifies as the structurally favored segment. Learn more at jiggle.cafe.
Industry analysts continue to emphasize that the clinical research validation of naturally derived caffeine ingredients is now reshaping how operators position products at retail. The brands gaining the most durable consumer preference are those that combine naturally sourced caffeine with verifiable ingredient transparency and clear dose disclosure.